Company Overview
Hypersonica is a Lithuania-based developer of hypersonic and aerospace technologies, operating in the dual-use defense and space sector. With revenue below €10M and still pre-commercial, the firm is at an early technology-validation stage, focused on propulsion systems, materials, and guidance IP that align with NATO Baltic defense priorities. Lithuania provides access to EU funding corridors and testing infrastructure, while the small domestic talent pool limits immediate scale.
Deal Context
The €23.3M Series A is framed as growth equity rather than a control transaction. The capital will fund prototype testing and certification, positioning the company as a potential acquisition or acqui-hire target for EU defense primes seeking hypersonic capabilities amid heightened NATO spending. Likely investors include specialist defense VCs and strategic corporates from France, Germany, and Sweden that already maintain Baltic supply-chain relationships.
Valuation Context
Listed Baltic peers trade at 5.4–15.1x EV/EBITDA, with a median near 8x. These multiples represent a ceiling for a mature industrial business; Hypersonica, being private, sub-€10M revenue, and pre-profit, warrants a 40–60% private-company discount plus an illiquidity haircut. Realistic entry pricing implies 4–7x forward revenue or roughly €15–25M post-money, consistent with the round size and well below listed defense multiples of 12–20x revenue observed in Western Europe.
Triage Verdict
GO
- Fit: Strong sector tailwinds from NATO Baltic buildup, Lithuania domicile, and credible defense-prime interest.
- Red flags: Limited commercial track record, heavy reliance on founder-led IP, and uncertain path to scaled manufacturing.
- Next step: Request data room on IP ownership, customer pipeline, and export-control compliance before committing.
Key Risk
Strict dual-use export controls could delay or block both revenue scaling and future exits to non-EU buyers.
Bottom line: Timely strategic exposure at an attractive entry multiple, provided export risks are contractually ring-fenced.
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Ma Investment Partnership, LP | $322.6B | +157.6% | 18 |
| 2 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +142.2% | 10 |
| 3 | Anther Capital Ltd | $3.8T | +137.8% | 31 |
| 4 | AIHC Capital Management Ltd | $226.4B | +126.4% | 11 |
| 5 | Central Asset Investments & Manag… | $261.4B | +125.8% | 63 |
| 6 | Merck & Co., Inc. | $625.7B | +120.4% | 26 |
| 7 | Oxbow Capital Management (HK) Ltd | $731.4B | +117.5% | 14 |
| 8 | Graticule Asia Macro Advisors LLC | $1.1T | +114.5% | 4 |
| 9 | Lunate Capital Ltd | $384.6B | +108.8% | 12 |
| 10 | Step Capital Management Pte. Ltd. | $467.4B | +106.7% | 53 |
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Research Alliance Corp IV | RACD | UNKNOWN | TBD | $75.0M |
| Aggreko Inc. | AGKO | UNKNOWN | TBD | $100.0M |
| Bitari Inc | BIAI | UNKNOWN | TBD | $34.5M |
| Cartesian Growth Corp IV | CGCFU | UNKNOWN | TBD | $287.5M |
| Company | Sector | Valuation |
|---|---|---|
| Anthropic | Artificial Intelligence | $965.0B |
| OpenAI | Artificial Intelligence | $894.3B |
| Databricks | Data and Analytics | $191.9B |
# Legal & Regulatory Reviewer You review legal and regulatory DD: corporate records, litigation, licensing, change-of-control. ## Output **Corporate & structure:** share register, board composition, material amendments, related-party transactions. **Open litigation:** table with: | Case | Jurisdiction | Status | Claim amount | Exposure | **Regulatory:** required licenses, active investigations, sanctions / GDPR / AML flags. **Change-of-control consents:** required at close — table with consent, counterparty, lead time. **Material contracts breach / amendment triggers on CoC.** **Bottom…